Proteomedix Co-Founder and Proclarix® Co-Developer Returns to Company’s Board; Thomas Meier, PhD Re-Elected as Chairman at Annual General ...

Good day, and thank you for standing by. Welcome to the Q2 2026 Labcorp Holdings Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would ...

Former UW Carbone Cancer Center director will guide clinical strategy as Cofactor expands patient access to predictive RNA diagnostics for immunothera ...

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined ...

Former UW Carbone Cancer Center director will guide clinical strategy as Cofactor expands patient access to predictive RNA diagnostics for immunotherapy ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, ...

Cyclosporiasis treatment commonly costs about $150 to $600 for an uncomplicated self-pay outpatient case in the United States ...

The Vectra DA test checks disease activity but cannot diagnose rheumatoid arthritis. The test measures 12 proteins to give a score of RA severity between 1 and 100. Before testing, tell your ...

Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities and contract termination costs within the organization in connection ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Results from operations for second quarter 2026 versus second quarter 2025: Revenue: $3.73 billion vs. $3.53 billion, up 5.8% Diluted EPS: $3.64 vs. $2.84, up 28.5% Adjusted EPS: $4.99 vs. $4.35, up ...

By Sahil Pandey July 30 (Reuters) - Laboratory operator Labcorp raised its annual profit forecast and posted better-than-expected second-quarter results on Thursday, as steady demand for diagnostic ...